{"id":"https://openalex.org/W1997286443","doi":"https://doi.org/10.1021/acs.jmedchem.5b00300","title":"The Discovery and Characterization of the \u03b1-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Potentiator N -{(3 S ,4 S )-4-[4-(5-Cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242)","display_name":"The Discovery and Characterization of the \u03b1-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Potentiator N -{(3 S ,4 S )-4-[4-(5-Cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242)","alternate_titles":[],"publication_year":2015,"publication_date":"2015-05-14","ids":{"openalex":"https://openalex.org/W1997286443","doi":"https://doi.org/10.1021/acs.jmedchem.5b00300","mag":"1997286443","pmid":"https://pubmed.ncbi.nlm.nih.gov/25905800"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.5b00300","doi":"https://doi.org/10.1021/acs.jmedchem.5b00300","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.5b00300","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1997286443"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051900776","display_name":"Christopher L. Shaffer","orcid":"https://orcid.org/0000-0002-7927-4914","observed_orcids":["https://orcid.org/0000-0002-7927-4914"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Christopher L. Shaffer","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014954738","display_name":"Nandini C. Patel","orcid":"https://orcid.org/0000-0002-2735-7662","observed_orcids":["https://orcid.org/0000-0002-2735-7662"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nandini C. Patel","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008671831","display_name":"Jacob B. Schwarz","orcid":"https://orcid.org/0000-0001-8645-8183","observed_orcids":["https://orcid.org/0000-0001-8645-8183"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jacob Schwarz","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011156074","display_name":"Renato J. Scialis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Renato J. Scialis","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045448432","display_name":"Yunjing Wei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yunjing Wei","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048435469","display_name":"Xinjun Hou","orcid":"https://orcid.org/0000-0002-3473-8455","observed_orcids":["https://orcid.org/0000-0002-3473-8455"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xinjun J. Hou","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103086595","display_name":"Longfei Xie","orcid":"https://orcid.org/0000-0001-7465-5729","observed_orcids":["https://orcid.org/0000-0001-7465-5729"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Longfei Xie","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kapil Karki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kapil Karki","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045329484","display_name":"Dianne K. Bryce","orcid":"https://orcid.org/0000-0002-2249-2240","observed_orcids":["https://orcid.org/0000-0002-2249-2240"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dianne K. Bryce","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113213832","display_name":"Sarah M. Osgood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sarah M. Osgood","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110572671","display_name":"William E. Hoffmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"William E. Hoffmann","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055125769","display_name":"John T. Lazzaro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John T. Lazzaro","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101987172","display_name":"Cheng Chang","orcid":"https://orcid.org/0000-0002-8189-9921","observed_orcids":["https://orcid.org/0000-0002-8189-9921"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cheng Chang","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040429390","display_name":"Dina McGinnis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dina F. McGinnis","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004362084","display_name":"Susan M. Lotarski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Susan M. Lotarski","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006384020","display_name":"Jianhua Liu","orcid":"https://orcid.org/0000-0001-7367-4493","observed_orcids":["https://orcid.org/0000-0001-7367-4493"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"JianHua Liu","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027820159","display_name":"Ronald Scott Obach","orcid":"https://orcid.org/0000-0002-6604-401X","observed_orcids":["https://orcid.org/0000-0002-6604-401X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. Scott Obach","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015738720","display_name":"Mark L. Weber","orcid":"https://orcid.org/0000-0001-8826-2029","observed_orcids":["https://orcid.org/0000-0001-8826-2029"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark L. Weber","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110943641","display_name":"Laigao M. Chen","orcid":"https://orcid.org/0009-0006-2358-758X","observed_orcids":["https://orcid.org/0009-0006-2358-758X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Laigao Chen","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113717935","display_name":"Kenneth R. Zasadny","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kenneth R. Zasadny","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110042374","display_name":"Patricia A. Seymour","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Patricia A. Seymour","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108749540","display_name":"Christopher J. Schmidt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christopher J. Schmidt","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031431090","display_name":"Mih\u00e1ly Haj\u00f3s","orcid":"https://orcid.org/0000-0002-5379-8576","observed_orcids":["https://orcid.org/0000-0002-5379-8576"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mih\u00e1ly Haj\u00f3s","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108229227","display_name":"Raymond S Hurst","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Raymond S. Hurst","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030686452","display_name":"Jayvardhan Pandit","orcid":"https://orcid.org/0000-0001-6128-7779","observed_orcids":["https://orcid.org/0000-0001-6128-7779"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jayvardhan Pandit","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043332165","display_name":"Christopher J. O\u2019Donnell","orcid":"https://orcid.org/0000-0003-1004-7139","observed_orcids":["https://orcid.org/0000-0003-1004-7139"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Christopher J. O\u2019Donnell","raw_affiliation_strings":["Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Dynamics and Metabolism, \u2021Neuroscience Research Unit, \u00a7Worldwide Medicinal Chemistry and ||BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5043332165","https://openalex.org/A5051900776"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.8397,"has_fulltext":false,"cited_by_count":35,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.63228532,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"58","issue":"10","first_page":"4291","last_page":"4308"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.8838000297546387,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.8838000297546387,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.032600000500679016,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.022700000554323196,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ampa-receptor-potentiators","display_name":"AMPA receptor potentiators","score":0.8889999985694885},{"id":"https://openalex.org/keywords/structure-based-drug-design","display_name":"structure-based drug design","score":0.8339999914169312},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.36800000071525574},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.9559999704360962},{"id":"https://openalex.org/keywords/pharmacokinetic-variability","display_name":"pharmacokinetic variability","score":0.640999972820282},{"id":"https://openalex.org/keywords/metabolic-stability","display_name":"metabolic stability","score":0.6179999709129333}],"concepts":[{"id":"https://openalex.org/C164718446","wikidata":"https://www.wikidata.org/wiki/Q7234839","display_name":"Potentiator","level":2,"score":0.9741183519363403},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9021800756454468},{"id":"https://openalex.org/C160268369","wikidata":"https://www.wikidata.org/wiki/Q295251","display_name":"AMPA receptor","level":4,"score":0.7998957633972168},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5541676878929138},{"id":"https://openalex.org/C2776701986","wikidata":"https://www.wikidata.org/wiki/Q278332","display_name":"Tetrahydrofuran","level":3,"score":0.47759127616882324},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3034995198249817},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.24821600317955017},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2480066418647766},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1569458544254303},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C2780471494","wikidata":"https://www.wikidata.org/wiki/Q146505","display_name":"Solvent","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008570","descriptor_name":"Memory, Short-Term","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011487","descriptor_name":"Protein Conformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018091","descriptor_name":"Receptors, AMPA","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/acs.jmedchem.5b00300","doi":"https://doi.org/10.1021/acs.jmedchem.5b00300","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.5b00300","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:25905800","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25905800","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":73,"referenced_works":["https://openalex.org/W1507804974","https://openalex.org/W1524874323","https://openalex.org/W1551264738","https://openalex.org/W1964587503","https://openalex.org/W1964634661","https://openalex.org/W1965634122","https://openalex.org/W1970468903","https://openalex.org/W1972146039","https://openalex.org/W1973412317","https://openalex.org/W1974716768","https://openalex.org/W1977467384","https://openalex.org/W1980413249","https://openalex.org/W1986006987","https://openalex.org/W1986541571","https://openalex.org/W1986908032","https://openalex.org/W1990416748","https://openalex.org/W1997051473","https://openalex.org/W2004097612","https://openalex.org/W2005690731","https://openalex.org/W2009316291","https://openalex.org/W2013514700","https://openalex.org/W2014078988","https://openalex.org/W2014887893","https://openalex.org/W2016425978","https://openalex.org/W2016575780","https://openalex.org/W2016971764","https://openalex.org/W2017616306","https://openalex.org/W2018021139","https://openalex.org/W2028884770","https://openalex.org/W2031953720","https://openalex.org/W2033307823","https://openalex.org/W2034108533","https://openalex.org/W2037849444","https://openalex.org/W2038155344","https://openalex.org/W2042721486","https://openalex.org/W2043941998","https://openalex.org/W2054976145","https://openalex.org/W2058858473","https://openalex.org/W2061119072","https://openalex.org/W2062856075","https://openalex.org/W2068333641","https://openalex.org/W2080092700","https://openalex.org/W2080640632","https://openalex.org/W2081659500","https://openalex.org/W2084120702","https://openalex.org/W2084253896","https://openalex.org/W2084820245","https://openalex.org/W2086760389","https://openalex.org/W2088289750","https://openalex.org/W2089167218","https://openalex.org/W2093248761","https://openalex.org/W2097030222","https://openalex.org/W2099677859","https://openalex.org/W2101479143","https://openalex.org/W2103218542","https://openalex.org/W2106721061","https://openalex.org/W2117140276","https://openalex.org/W2118223016","https://openalex.org/W2122387933","https://openalex.org/W2128527026","https://openalex.org/W2128574573","https://openalex.org/W2141486146","https://openalex.org/W2143242847","https://openalex.org/W2144292852","https://openalex.org/W2150249789","https://openalex.org/W2150310953","https://openalex.org/W2150823598","https://openalex.org/W2152697634","https://openalex.org/W2156035025","https://openalex.org/W2328088698","https://openalex.org/W2356379002","https://openalex.org/W4300904188","https://openalex.org/W4406065843"],"related_works":["https://openalex.org/W2106721061","https://openalex.org/W1971449549","https://openalex.org/W1971748040","https://openalex.org/W2017616306","https://openalex.org/W3125481334","https://openalex.org/W2953609208","https://openalex.org/W4321794044","https://openalex.org/W1987702456"],"abstract_inverted_index":{"A":[0],"unique":[1],"tetrahydrofuran":[2,42],"ether":[3],"class":[4],"of":[5,55],"highly":[6],"potent":[7],"\u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic":[8],"acid":[9],"receptor":[10],"potentiators":[11],"has":[12],"been":[13],"identified":[14],"using":[15],"rational":[16],"and":[17,29,67],"structure-based":[18],"drug":[19],"design.":[20],"An":[21],"acyclic":[22],"lead":[23],"compound,":[24],"containing":[25],"an":[26,78],"ether-linked":[27],"isopropylsulfonamide":[28],"biphenyl":[30],"group,":[31],"was":[32],"pharmacologically":[33],"augmented":[34],"by":[35,83],"converting":[36],"it":[37],"to":[38,43,62,96],"a":[39],"conformationally":[40],"constrained":[41],"improve":[44],"key":[45],"interactions":[46],"with":[47,60,102],"the":[48,56],"human":[49,86],"GluA2":[50],"ligand-binding":[51],"domain.":[52],"Subsequent":[53],"replacement":[54],"distal":[57],"phenyl":[58],"motif":[59],"2-cyanothiophene":[61],"enhance":[63],"its":[64,94],"potency,":[65],"selectivity,":[66],"metabolic":[68],"stability":[69],"afforded":[70],"N-{(3S,4S)-4-[4-(5-cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide":[71],"(PF-04958242,":[72],"3),":[73],"whose":[74],"preclinical":[75],"characterization":[76],"suggests":[77],"adequate":[79],"therapeutic":[80],"index,":[81],"aided":[82],"low":[84],"projected":[85],"oral":[87],"pharmacokinetic":[88],"variability,":[89],"for":[90],"clinical":[91],"studies":[92],"exploring":[93],"ability":[95],"attenuate":[97],"cognitive":[98],"deficits":[99],"in":[100],"patients":[101],"schizophrenia.":[103]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1997286443","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
